文献速递妇产影像US

双胎输血综合征合并选择性胎儿生长受限行激光手术后的结局:系统综述与Meta分析

Outcome following laser surgery of twin-twin transfusion syndrome complicated by selective fetal growth restriction: systematic review and meta-analysis.
PubMed 文献 · Ultrasound Obstet Gynecol · 2023-01-01

该系统综述与Meta分析纳入5项研究(1710例单绒毛膜双羊膜囊双胎妊娠),比较双胎输血综合征(TTTS)合并与未合并选择性胎儿生长受限(sFGR)行激光手术后的结局。合并sFGR者术后总体胎儿丢失风险显著更高(20.90% vs 14.42%,合并OR 1.6,95%CI 1.3-1.9,P<0.001),且供血儿神经病学发病率显著升高(合并OR 2.4,95%CI 1.1-5.2,P=0.029),但早产风险无显著差异。

要点

  • TTTS合并sFGR者激光术后总体胎儿丢失风险显著高于未合并sFGR者(20.90% vs 14.42%,合并OR 1.6,95%CI 1.3-1.9,P<0.001)
  • 胎儿丢失风险升高主要见于供血儿,受血儿无显著差异
  • 合并sFGR者神经病学发病率显著更高(合并OR 1.8,95%CI 1.1-2.9,P=0.034),供血儿尤为显著(合并OR 2.4,95%CI 1.1-5.2,P=0.029)

核心结论

  • 在单绒毛膜双羊膜囊双胎妊娠中,TTTS合并sFGR是激光手术后胎儿丢失的额外风险因素;该Meta分析结果可能有助于对合并TTTS的双胎妊娠进行个体化风险评估及激光手术前的针对性父母咨询。

研究设计与样本

  • 系统综述与随机效应Meta分析,检索MEDLINE、EMBASE和Cochrane数据库,纳入报告单绒毛膜双羊膜囊双胎妊娠合并TTTS行激光治疗且合并或不合并sFGR的研究;5项研究(1710例单绒毛膜双羊膜囊双胎妊娠)纳入定性合成,4项纳入Meta分析。

诊断标准与关键数值

  • TTTS合并sFGR者激光术后总体胎儿丢失(流产和宫内死亡)为20.90%,未合并sFGR者为14.42%,合并OR 1.6(95%CI 1.3-1.9)(P<0.001)
  • 活产双胎率在合并sFGR者为79.1%(95%CI 72.6-84.9%),未合并sFGR者为85.6%(95%CI 81.0-89.6%),合并OR 0.6(95%CI 0.5-0.8)(P<0.001)
  • 神经病学发病率在合并sFGR者显著更高(合并OR 1.8,95%CI 1.1-2.9,P=0.034),供血儿合并OR 2.4(95%CI 1.1-5.2)(P=0.029),受血儿无显著差异(P=0.361)
  • 无神经损害生存率在合并sFGR者为70.8%(95%CI 45.0-91.0%),未合并sFGR者为75.8%(95%CI 51.9-93.3%),两组无差异
  • 早产<32周(P=0.308)和<28周(P=0.310)风险两组无显著差异;复合发病率(P=0.506)和呼吸系统发病率(P=0.531)两组无显著差异

临床应用与阅片要点

  • 该Meta分析结果可能有助于对合并TTTS的双胎妊娠进行个体化风险评估,并在激光手术前为父母提供针对性咨询。

局限性

  • 短期和长期发病率的评估受到病例数少的限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The published literature reports mostly on the outcome of twin pregnancies complicated by twin-twin transfusion syndrome (TTTS) without considering whether the pregnancy is also complicated by another pathology, such as selective fetal growth restriction (sFGR). The aim of this systematic review was to report on the outcome of monochorionic diamniotic (MCDA) twin pregnancies undergoing laser surgery for TTTS that were complicated by sFGR and those not complicated by sFGR.

METHODS: MEDLINE, EMBASE and Cochrane databases were searched. The inclusion criteria were studies reporting on MCDA twin pregnancies with TTTS undergoing laser therapy that were complicated by sFGR and those not complicated by sFGR. The primary outcome was the overall fetal loss following laser surgery, defined as miscarriage and intrauterine death. The secondary outcomes included fetal loss within 24 h after laser surgery, survival at birth, preterm birth (PTB) prior to 32 weeks of gestation, PTB prior to 28 weeks, composite neonatal morbidity, neurological and respiratory morbidity, and survival free from neurological impairment. All outcomes were explored in the overall population of twin pregnancies complicated by sFGR vs those not complicated by sFGR in the setting of TTTS and in the donor and recipient twins separately. Random-effects meta-analysis was used to combine data and the results are reported as pooled odds ratios (OR) with 95% CI.

RESULTS: Five studies (1710 MCDA twin pregnancies) were included in the qualitative synthesis and four in the meta-analysis. The overall risk of fetal loss after laser surgery was significantly higher in MCDA twin pregnancies with TTTS complicated by sFGR (20.90% vs 14.42%), with a pooled OR of 1.6 (95% CI, 1.3-1.9) (P < 0.001). The risk of fetal loss was significantly higher in MCDA twin pregnancies with TTTS and sFGR for the donor but not for the recipient twin. The rate of live twins was 79.1% (95% CI, 72.6-84.9%) in TTTS pregnancies with sFGR and 85.6% (95% CI, 81.0-89.6%) in those without sFGR (pooled OR, 0.6 (95% CI, 0.5-0.8)) (P < 0.001). There was no significant difference in the risk of PTB prior to 32 weeks of gestation (P = 0.308) or prior to 28 weeks (P = 0.310). Assessment of short- and long-term morbidity was affected by the small number of cases. There was no significant difference in the risk of composite (P = 0.506) or respiratory (P = 0.531) morbidity between twins complicated by TTTS with vs those without sFGR, while the risk of neurological morbidity was significantly higher in those with TTTS and sFGR (pooled OR, 1.8 (95% CI, 1.1-2.9)) (P = 0.034). The risk of neurological morbidity was significantly higher for the donor twin (pooled OR, 2.4 (95% CI, 1.1-5.2)) (P = 0.029) but not for the recipient twin (P = 0.361). Survival free from neurological impairment was observed in 70.8% (95% CI, 45.0-91.0%) of twin pregnancies with TTTS complicated by sFGR and in 75.8% (95% CI, 51.9-93.3%) of those not complicated by sFGR, with no difference between the two groups.

CONCLUSIONS: sFGR in MCDA pregnancies with TTTS represents an additional risk factor for fetal loss following laser surgery. The findings of this meta-analysis may be useful for individualized risk assessment of twin pregnancy complicated by TTTS and tailored counseling of the parents prior to laser surgery. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. D'Antonio F, Marinceu D, Prasad S, et al. Outcome following laser surgery of twin-twin transfusion syndrome complicated by selective fetal growth restriction: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2023. PMID: 37204823. doi:10.1002/uog.26252

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。